Literature DB >> 22874769

Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway.

Virginie Granci1, Fang Cai, Elena Lecumberri, Aurélie Clerc, Yves M Dupertuis, Claude Pichard.   

Abstract

Adjuvant use of safe compounds with anti-tumour properties has been proposed to improve cancer chemotherapy outcome. We aimed to investigate the effects of fish oil emulsion (FOE) rich in n-3 PUFA with the standard chemotherapeutic agents 5-fluorouracil (5-FU), oxaliplatin (OX) or irinotecan (IRI) on two human colorectal adenocarcinoma cells with different genetic backgrounds. The HT-29 (Bax+/+) and LS174T (Bax-/-) cells were co-treated for 24-72 h with 1 μm-5-FU, 1 μm-OX or 10 μm-IRI and/or FOE dilution corresponding to 24 μm-EPA and 20·5 μm-DHA. Soyabean oil emulsion (SOE) was used as isoenergetic and isolipid control. Cell viability, apoptosis and nuclear morphological changes were evaluated by cytotoxic colorimetric assay, flow cytometry analysis with annexin V and 4',6'-diamidino-2-phenylindole staining, respectively. A cationic fluorescent probe was used to evaluate mitochondrial dysfunction, and protein expression involved in mitochondrial apoptosis was determined by Western blot. In contrast to SOE, co-treatment with FOE enhanced significantly the pro-apoptotic and cytotoxic effects of 5-FU, OX or IRI in HT-29 but not in LS174T cells (two-way ANOVA, P <0.01). These results were confirmed by the formation of apoptotic bodies in HT-29 cells. A significant increase in mitochondrial membrane depolarisation was observed after the combination of 5-FU or IRI with FOE in HT-29 but not in LS174T cells (P <0.05). Co-administration of FOE with the standard agents, 5-FU, OX and IRI, could be a good alternative to increase the efficacy of chemotherapeutic protocols through a Bax-dependent mitochondrial pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874769     DOI: 10.1017/S000711451200308X

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  20 in total

1.  Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.

Authors:  Marnie Newell; Susan Goruk; Vera Mazurak; Lynne Postovit; Catherine J Field
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

Review 2.  Omega-3 fatty acids, membrane remodeling and cancer prevention.

Authors:  Natividad R Fuentes; Eunjoo Kim; Yang-Yi Fan; Robert S Chapkin
Journal:  Mol Aspects Med       Date:  2018-04-12

3.  Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.

Authors:  Kun Gao; Qi Liang; Zhi-Hao Zhao; You-Fen Li; Shu-Feng Wang
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 4.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

5.  n-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention.

Authors:  Zhennan Gu; Kai Shan; Haiqin Chen; Yong Q Chen
Journal:  Curr Pharmacol Rep       Date:  2015-07-05

Review 6.  Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies - exemplified by polyunsaturated fatty acids and other ROS-modulating agents.

Authors:  Rui Xue Zhang; Franky Fuh-Ching Liu; Hoyin Lip; Junhong Liu; Qianrong Zhang; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2022-01-22       Impact factor: 5.671

Review 7.  Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.

Authors:  Nicolò Merendino; Lara Costantini; Laura Manzi; Romina Molinari; Donatella D'Eliseo; Francesca Velotti
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

8.  Fish oil administration mediates apoptosis of Walker 256 tumor cells by modulation of p53, Bcl-2, caspase-7 and caspase-3 protein expression.

Authors:  Gina Borghetti; Adriana Aya Yamaguchi; Julia Aikawa; Ricardo Key Yamazaki; Gleisson Alisson Pereira de Brito; Luiz Claudio Fernandes
Journal:  Lipids Health Dis       Date:  2015-08-25       Impact factor: 3.876

9.  Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition.

Authors:  Giada Gelsomino; Paola A Corsetto; Ivana Campia; Gigliola Montorfano; Joanna Kopecka; Barbara Castella; Elena Gazzano; Dario Ghigo; Angela M Rizzo; Chiara Riganti
Journal:  Mol Cancer       Date:  2013-11-13       Impact factor: 27.401

Review 10.  Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy.

Authors:  Donatella D'Eliseo; Francesca Velotti
Journal:  J Clin Med       Date:  2016-01-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.